• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES LLC SAPIEN 3 ULTRA SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES LLC SAPIEN 3 ULTRA SYSTEM; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9750CM26
Device Problems Material Rupture (1546); Mechanical Jam (2983); Output Problem (3005)
Patient Problem Insufficient Information (4580)
Event Date 01/13/2022
Event Type  Injury  
Event Description
Cardiologist's explanation.Under ultrasonic guidance, with the use of micropuncture needle, an access was made in right common femoral artery, and a 6 french sheath was inserted.Over the wire 2 perclose sutures were placed and with the help of amplatzer extra stiff wire, a 14 french e-sheath+ was inserted.The valve was advanced through the 14 french sheath and positioned at the aortic annulus under fluoroscopic guidance.The valve was positioned and replaced using standard technique.During valve deployment, there was rupture of the balloon which was immediately identified.The balloon was attempted to be retrieved into the sheath but there was flaring of the esheath+.Therefore we removed the sheath and the ruptured balloon en mass.We exchanged for a stiffer lunderquist wire and continued slowly removing the sheath and it got stuck at the femoral access site.Thereafter a cutdown was performed.Cardiac surgeon's explanation.Ultrasound guided percutaneous access was obtained on the right common femoral artery.The right common femoral artery was "preclosed" with 2 per close devices, and using standard techniques, a 14 french hemostatic sheath was secured in place.Anticoagulation was initiated with heparin.The aortic valve was crossed and with a series of exchanges a safari wire was advanced to the lv apex.After confirmation of correct orientation of the 26 mm s3 ultra valve on the delivery catheter, the valve was crimped and loaded onto the delivery catheter which was then advanced over the exchange wire into the descending aorta.Proper alignment with the valve and balloon on the delivery catheter was achieved. the valve was advanced across the aortic valve. with rapid pacing and under fluoroscopic guidance, the valve was positioned precisely across the aortic valve, and the valve was deployed.Unfortunately the balloon ruptured just at full deployment.Rapid pacing was ceased, and the balloon and delivery system were retracted into the descending aorta without issue.At this point, the delivery system was able to be retracted to the distal external iliac without issue; however, it was not able to be pulled out of the artery.A cutdown on the right femoral artery was done to retrieve it.Days after surgery, an echo showed normal ejection fraction, and a well-functioning valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 ULTRA SYSTEM
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES LLC
one edwards way
irvine CA 92614
MDR Report Key14619091
MDR Text Key293452732
Report Number14619091
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 05/31/2022,05/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9750CM26
Device Catalogue Number9750CM26A
Device Lot Number64009600
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/31/2022
Event Location Hospital
Date Report to Manufacturer06/07/2022
Initial Date Manufacturer Received Not provided
Initial Date FDA Received06/07/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age31755 DA
Patient SexFemale
Patient Weight59 KG
Patient RaceWhite
-
-